acetylcysteine has been researched along with Chronic Kidney Diseases in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (14.29) | 29.6817 |
| 2010's | 21 (60.00) | 24.3611 |
| 2020's | 9 (25.71) | 2.80 |
| Authors | Studies |
|---|---|
| Bateman, DN; Briody, L; Cameron, S; Dhaun, N; Eddleston, M; Goddard, J; Gray, T; Hickson, K; Johnston, NR; Megson, IL; Morrison, EE; Norrie, J; Raja, K; Rees, JMB; Rushworth, G; Sandilands, EA; Thompson, AP; Treweeke, A; Uren, N; Webb, DJ; Wraight, J | 1 |
| Biswas, S; Roy, T; Sengupta, P | 1 |
| Dong, W; Gong, Z; Li, J; Liu, G; Liu, Z; Luo, T; Ma, Y; Song, R; Wang, X; Zhang, K; Zhu, J; Zou, H | 1 |
| Cepaityte, D; Leivaditis, K; Liakopoulos, V; Roumeliotis, A; Roumeliotis, S; Varouktsi, G | 1 |
| Abdulazim, DO; Amin, M; Csongradi, E; ElAzim, IMA; Elhadidy, S; Fayed, A; Hammad, AA; Hammad, H; Salem, MM; Sharaf El Din, UA; Soliman, KM; Zsom, L | 1 |
| Biederman, L; Brodsky, SV; Dasgupta, A; Ivanov, I; Medipally, A; Mikhalina, G; Rovin, B; Satoskar, AA; Xiao, M | 1 |
| Anderson, EM; Berceli, SA; Cort, TA; Dong, G; Fazzone, B; Kim, K; Kunz, EM; Moerschel, J; Moparthy, CN; O'Malley, KA; Palzkill, VR; Robinson, ST; Ryan, TE; Scali, ST | 1 |
| Khajeh Dalooee, M; Moosavi Nik, S; Naghibi, M; Raeesi, V; Samadi, K; Samadi, M; Shabestari, M; Sharifipour, F | 1 |
| Amin, A; Barón, AE; Gilmartin, HM; Keach, JW; Langner, P; Maddox, TM; Plomondon, ME; Stanislawski, MA; Waldo, S | 1 |
| Chien, WC; Chung, CH; Liao, CY; Lin, FH; Tsao, CH; Wang, CC; Wu, CC | 1 |
| Androsenko, M; Bhatt, DL; Brophy, M; Cass, A; Chertow, GM; Conner, TA; Ferguson, R; Gallagher, M; Garcia, S; Jneid, H; Kaufman, J; McFalls, EO; Myles, J; Palevsky, PM; Parikh, CR; Shunk, K; Thwin, SS; Weisbord, SD; Wu, H | 1 |
| Solomon, R | 1 |
| Brooks, HL; Coombes, JS; Gobe, GC; Johnson, DW; Morais, C; Roy, SF; Sanchez, WY; Small, DM | 1 |
| Hou, FF; Li, C; Li, Y; Liu, C; Wang, J; Xie, N | 1 |
| He, G; Li, Q; Li, W; Wang, L; Yang, J; Zeng, F | 1 |
| Alberts, BM; Basnayake, K; Bruce, C; Davies, KA; Ghezzi, P; Mullen, LM | 1 |
| Fratita, M; Owens, R; O’Dwyer, M; Spring, A | 1 |
| Bennett, NC; Gabrielli, BG; Gobe, GC; Johnson, DW; Roy, S; Small, DM | 1 |
| Aresmouk, D; Berndt, S; Grebe, SO; Herget-Rosenthal, S; Langenbeck, M; Schaper, A | 1 |
| Axelsson, J; Ellis, E; Li, M; Qureshi, AR | 1 |
| Adelibieke, Y; Lee, CT; Ng, HY; Nishijima, F; Niwa, T; Saito, S; Yisireyili, M | 1 |
| Li, J; Xu, G; Yan, W | 1 |
| Brodsky, SV; Hebert, LA; Ivanov, I; Muni, N; Nadasdy, G; Nadasdy, T; Rovin, BH; Satoskar, AA; Vance, JC; Ware, KM | 1 |
| Dallin, FT; França, KC; Fujihara, CK; Nakao, LS; Nascimento, AJ; Pecoits-Filho, R; Rodrigues, SD | 1 |
| Atar, S; Eizenberg, S; Feldman-Idov, Y; Kristal, B; Marzuq, N; Ofir, P; Shema-Didi, L; Sussan, M | 1 |
| Azevedo, M; Barreto, FC; Bonan, NB; Kotanko, P; Kuntsevich, V; Moreno-Amaral, AN; Nakao, LS; Pecoits-Filho, R; Ronco, C; Steiner, TM; Thijssen, S; Virzì, GM | 1 |
| Huang, T; Wang, L; Xu, G; Yan, W | 1 |
| Amini, M; Amirbaigloo, A; Esfahani, F; Masoudkabir, F; Salarifar, M | 1 |
| Amato, M; Bellandi, F; Gallopin, M; Leoncini, M; Maioli, M; Manzone, C; Micheletti, C; Tedeschi, D; Toso, A | 1 |
| Crum, A; Kovacheva, E; Norris, KC; Shen, R; Sinha-Hikim, I; Vaziri, ND | 1 |
| Bateman, N; Briody, L; Cameron, S; Crowe, J; Donaldson, S; Donnelly, J; Eddleston, M; Goddard, J; Johnston, NR; Mackenzie, I; Megson, IL; Paterson, F; Sandilands, EA; Thompson, A; Uren, N; Webb, DJ | 1 |
| Airoldi, F; Briguori, C; Carlino, M; Colombo, A; Condorelli, G; Focaccio, A; Montorfano, M; Morici, N; Ricciardelli, B; Sangiorgi, GM; Violante, A | 1 |
| Krizova, B; Sochman, J | 1 |
| Enomoto, S; Hoshino, A; Kawahito, H; Kurata, H; Nakahara, Y; Nakamura, T | 1 |
| Bortone, F; Ceriani, R; Fiorentini, C; Juliano, G; Marenzi, G; Salvi, L; Sisillo, E; Veglia, F | 1 |
3 review(s) available for acetylcysteine and Chronic Kidney Diseases
| Article | Year |
|---|---|
N-Acetylcysteine: more than preventing contrast-induced nephropathy in uremic patients-focus on the antioxidant and anti-inflammatory properties.
Topics: Acetylcysteine; Anti-Inflammatory Agents; Antioxidants; Humans; Kidney Failure, Chronic; Oxidative Stress; Reactive Oxygen Species; Renal Insufficiency, Chronic | 2023 |
N-Acetylcysteine for Preventing of Acute Kidney Injury in Chronic Kidney Disease Patients Undergoing Cardiac Surgery: A Metaanalysis.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Oral; Anti-Inflammatory Agents; Antioxidants; Cardiac Surgical Procedures; Humans; Infusions, Intravenous; Intensive Care Units; Length of Stay; Postoperative Complications; Renal Insufficiency, Chronic; Renal Replacement Therapy | 2018 |
An update for the controversies and hypotheses of regulating nonthyroidal illness syndrome in chronic kidney diseases.
Topics: Acetylcysteine; Comorbidity; Cytokines; Disease Progression; Euthyroid Sick Syndromes; Hormone Replacement Therapy; Humans; Oxidative Stress; Renal Insufficiency, Chronic; Sodium Bicarbonate; Thyroid Hormones | 2014 |
13 trial(s) available for acetylcysteine and Chronic Kidney Diseases
| Article | Year |
|---|---|
Acetylcysteine has No Mechanistic Effect in Patients at Risk of Contrast-Induced Nephropathy: A Failure of Academic Clinical Science.
Topics: Acetylcysteine; Antioxidants; Contrast Media; Creatinine; Cross-Over Studies; Humans; Kidney Diseases; Renal Insufficiency, Chronic; Treatment Outcome | 2022 |
Comparative Study to Evaluate the Effect of Low-Protein Diet Supplementation with Taurine and N-Acetylcysteine, N-Acetylcysteine and Pyridoxamine Dihydrochloride in Preventing the Progression of Chronic Renal Failure in Patients with Non-Diabetic Kidney D
Topics: Acetylcysteine; Adult; Aged; Diet, Protein-Restricted; Dietary Supplements; Disease Progression; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pyridoxamine; Renal Insufficiency, Chronic; Taurine | 2022 |
Is the combination of linagliptin and allopurinol better prophylaxis against post-contrast acute kidney injury? A multicenter prospective randomized controlled study.
Topics: Acetylcysteine; Acute Kidney Injury; Allopurinol; Chemoprevention; Contrast Media; Diabetic Nephropathies; Drug Therapy, Combination; Humans; Kidney Failure, Chronic; Linagliptin; Prospective Studies; Protective Agents; Renal Insufficiency, Chronic; Saline Solution | 2023 |
Evaluation the Effects of Alpha-tocopherol in Comparison with N-acetylcystein for Prevention of Contrast Induced Nephropathy (CIN) in CKD Patients.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; alpha-Tocopherol; Contrast Media; Coronary Angiography; Creatinine; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Prospective Studies; Renal Insufficiency, Chronic; Sodium Chloride | 2020 |
Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Oral; Aged; Angiography; Contrast Media; Creatinine; Double-Blind Method; Female; Fluid Therapy; Humans; Infusions, Intravenous; Male; Middle Aged; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors; Sodium Bicarbonate; Sodium Chloride; Treatment Outcome | 2018 |
Impaired postprandial fibroblast growth factor (FGF)-19 response in patients with stage 5 chronic kidney diseases is ameliorated following antioxidative therapy.
Topics: Acetylcysteine; Adult; Aged; Antioxidants; Biomarkers; Blood Glucose; Blueberry Plants; Case-Control Studies; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Fibroblast Growth Factors; Humans; Insulin; Male; Middle Aged; Phytotherapy; Postprandial Period; Prognosis; Renal Dialysis; Renal Insufficiency, Chronic; Triglycerides; Young Adult | 2013 |
Prevention of contrast-induced nephropathy with single bolus erythropoietin in patients with diabetic kidney disease: A randomized controlled trial.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Aged, 80 and over; Biomarkers; Contrast Media; Coronary Angiography; Cystatin C; Cytoprotection; Diabetic Nephropathies; Double-Blind Method; Drug Administration Schedule; Erythropoietin; Female; Humans; Infusions, Intravenous; Iohexol; Israel; Lipocalin-2; Male; Middle Aged; Prospective Studies; Protective Agents; Recombinant Proteins; Renal Insufficiency, Chronic; Risk Factors; Time Factors; Treatment Outcome; Triiodobenzoic Acids | 2016 |
Treatment for non-thyroidal illness syndrome in advanced chronic kidney disease: a single-blind controlled study.
Topics: Acetylcysteine; Chi-Square Distribution; China; Disease Progression; Euthyroid Sick Syndromes; Female; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Proportional Hazards Models; Renal Insufficiency, Chronic; Risk Factors; Single-Blind Method; Sodium Bicarbonate; Time Factors; Treatment Outcome | 2017 |
N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial.
Topics: Acetylcysteine; Administration, Oral; Aged; Cardiac Catheterization; Contrast Media; Coronary Angiography; Creatinine; Diabetes Mellitus; Female; Free Radical Scavengers; Humans; Incidence; Kidney Diseases; Male; Middle Aged; Placebos; Prospective Studies; Renal Insufficiency, Chronic; Risk Factors | 2009 |
Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Atorvastatin; Biomarkers; Contrast Media; Coronary Angiography; Creatinine; Female; Fluid Therapy; Heptanoic Acids; Humans; Male; Prospective Studies; Pyrroles; Renal Insufficiency, Chronic; Risk Factors | 2010 |
Mechanisms for an effect of acetylcysteine on renal function after exposure to radio-graphic contrast material: study protocol.
Topics: Acetylcysteine; Acute-Phase Proteins; Contrast Media; Cross-Over Studies; Cystatin C; Glomerular Filtration Rate; Hepatitis A Virus Cellular Receptor 1; Humans; Kidney; Lipocalin-2; Lipocalins; Male; Membrane Glycoproteins; Middle Aged; Natriuresis; Proto-Oncogene Proteins; Receptors, Virus; Renal Circulation; Renal Insufficiency, Chronic | 2012 |
Prevention of contrast agent-induced renal impairment in patients with chronic renal insufficiency and heart disease by high-dose intravenous N-acetylcysteine: a pilot-ministudy.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Coronary Angiography; Creatinine; Heart Diseases; Humans; Infusions, Intravenous; Pilot Projects; Poland; Premedication; Renal Insufficiency, Chronic; Safety; Treatment Outcome | 2006 |
N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Creatinine; Female; Free Radical Scavengers; Heart Diseases; Humans; Length of Stay; Male; Prospective Studies; Renal Insufficiency, Chronic; Renal Replacement Therapy; Treatment Outcome | 2008 |
19 other study(ies) available for acetylcysteine and Chronic Kidney Diseases
| Article | Year |
|---|---|
N-acetylcysteine delayed cadmium-induced chronic kidney injury by activating the sirtuin 1-P53 signaling pathway.
Topics: Acetylcysteine; Animals; Cadmium; Cellular Senescence; Fibrosis; Kidney; Rats; Renal Insufficiency, Chronic; Signal Transduction; Sirtuin 1; Tumor Suppressor Protein p53 | 2023 |
N-acetylcysteine ameliorates hematuria-associated tubulointerstitial injury in 5/6 nephrectomy mice.
Topics: Acetylcysteine; Animals; Fibrosis; Hematuria; Humans; Kidney; Mice; Mice, Inbred C57BL; Nephrectomy; Rats; Reactive Oxygen Species; Renal Insufficiency, Chronic; Tumor Necrosis Factor-alpha; Warfarin | 2023 |
Topics: Acetylcysteine; Animals; Arteriovenous Fistula; Arteriovenous Shunt, Surgical; Female; Kidney Failure, Chronic; Male; Mice; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies | 2023 |
Variation in contrast-associated acute kidney injury prophylaxis for percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Female; Fluid Therapy; Free Radical Scavengers; Glomerular Filtration Rate; Heart Failure; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Perioperative Care; Postoperative Complications; Practice Guidelines as Topic; Renal Insufficiency, Chronic; Saline Solution; Sodium Bicarbonate; United States; Veterans Health Services | 2020 |
Protective effect of N-acetylcysteine on progression to end-stage renal disease: Necessity for prospective clinical trial.
Topics: Acetylcysteine; Adolescent; Adult; Comorbidity; Disease Progression; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Propensity Score; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Risk Reduction Behavior; Survival Analysis; Taiwan; Young Adult | 2017 |
Acute kidney injury: Antioxidants do not PRESERVE kidney function after contrast exposure.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Oral; Aged; Angiography; Contrast Media; Creatinine; Double-Blind Method; Female; Fluid Therapy; Humans; Infusions, Intravenous; Male; Middle Aged; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors; Sodium Bicarbonate; Sodium Chloride; Treatment Outcome | 2018 |
N-acetyl-cysteine increases cellular dysfunction in progressive chronic kidney damage after acute kidney injury by dampening endogenous antioxidant responses.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antioxidants; Apoptosis; Cell Proliferation; Disease Models, Animal; Disease Progression; Energy Metabolism; Kidney; Male; Mice, Inbred C57BL; Microscopy, Fluorescence, Multiphoton; Mitochondria; NAD; Oxidative Stress; Phosphorylation; PPAR gamma; Renal Insufficiency, Chronic; Signal Transduction; Time Factors; Transforming Growth Factor beta1 | 2018 |
N-acetylcysteine ameliorates cisplatin-induced renal senescence and renal interstitial fibrosis through sirtuin1 activation and p53 deacetylation.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antioxidants; Cellular Senescence; Cisplatin; Fibrosis; Humans; Kidney; Mice; Oxidative Stress; Rats; Renal Insufficiency, Chronic; Sirtuin 1; Tumor Suppressor Protein p53 | 2019 |
Secretion of IL-1β From Monocytes in Gout Is Redox Independent.
Topics: Acetylcysteine; Antioxidants; Cell Survival; Furans; Gene Expression; Gout; Heterocyclic Compounds, 4 or More Rings; Humans; Hyperuricemia; Indenes; Inflammasomes; Interleukin-1beta; Lipopeptides; Monocytes; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Renal Insufficiency, Chronic; Sulfonamides; Sulfones; Superoxide Dismutase; Thioredoxin Reductase 1; Toll-Like Receptor 2; Uric Acid | 2019 |
An Under-Recognised Cause of Iatrogenic, Severe Metabolic Acidosis
Topics: Acetaminophen; Acetylcysteine; Acidosis; Aged, 80 and over; Anti-Bacterial Agents; Antipyretics; Arthroplasty, Replacement, Hip; Blood Gas Analysis; Drug Interactions; Floxacillin; Hip Prosthesis; Humans; Iatrogenic Disease; Male; Prosthesis-Related Infections; Pyrrolidonecarboxylic Acid; Renal Insufficiency, Chronic; Renal Replacement Therapy; Severity of Illness Index; Sodium Bicarbonate; Staphylococcal Infections; Surgical Wound Infection | 2019 |
Oxidative stress and cell senescence combine to cause maximal renal tubular epithelial cell dysfunction and loss in an in vitro model of kidney disease.
Topics: Acetylcysteine; Apigenin; Apoptosis; Cell Line; Cellular Senescence; Epithelial Cells; Humans; Hydrogen Peroxide; Kidney; Kidney Tubules; Lipid Peroxidation; Mitochondria; Oxidative Stress; Regeneration; Renal Insufficiency, Chronic | 2012 |
Antioxidant treatment and outcome of Cortinarius orellanus poisoning: a case series.
Topics: Acetylcysteine; Acute Kidney Injury; Adrenal Cortex Hormones; Adult; Cortinarius; Drug Therapy, Combination; Female; Free Radical Scavengers; Humans; Male; Middle Aged; Mushroom Poisoning; Renal Insufficiency, Chronic | 2013 |
Indoxyl sulfate downregulates expression of Mas receptor via OAT3/AhR/Stat3 pathway in proximal tubular cells.
Topics: Acetylcysteine; Angiotensins; Animals; Down-Regulation; Humans; Immunohistochemistry; Indican; Kidney Tubules, Proximal; Male; Models, Biological; Nitric Oxide Synthase Type III; Organic Anion Transporters, Sodium-Independent; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Inbred Dahl; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Aryl Hydrocarbon; Receptors, G-Protein-Coupled; Renal Insufficiency, Chronic; RNA, Small Interfering; Signal Transduction; STAT3 Transcription Factor; Time Factors; Transforming Growth Factor beta1 | 2014 |
Oral warfarin and the thrombin inhibitor dabigatran increase blood pressure in rats: hidden danger of anticoagulants?
Topics: Acetylcysteine; Animals; Anticoagulants; Antifibrinolytic Agents; Antithrombins; Benzimidazoles; beta-Alanine; Blood Pressure; Dabigatran; Disease Models, Animal; Dose-Response Relationship, Drug; Free Radical Scavengers; Nephrectomy; Pyrroles; Quinazolines; Rats; Receptor, PAR-1; Renal Insufficiency, Chronic; Vitamin K; Warfarin | 2015 |
N-acetylcysteine as a potential strategy to attenuate the oxidative stress induced by uremic serum in the vascular system.
Topics: Acetylcysteine; Adult; Aged; Animals; Biomarkers; Blood Vessels; Cells, Cultured; Female; Free Radical Scavengers; Glutathione; Humans; Male; Middle Aged; Myocytes, Smooth Muscle; Nephrectomy; Oxidative Stress; Rabbits; Rats; Rats, Wistar; Reactive Oxygen Species; Renal Insufficiency, Chronic; Uremia | 2015 |
Uremic Toxicity-Induced Eryptosis and Monocyte Modulation: The Erythrophagocytosis as a Novel Pathway to Renal Anemia.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Case-Control Studies; Coculture Techniques; Eryptosis; Erythrocytes; Female; Free Radical Scavengers; Gene Expression Regulation; GPI-Linked Proteins; Humans; Immune Sera; Lipopolysaccharide Receptors; Male; Middle Aged; Monocytes; Phagocytosis; Primary Cell Culture; Reactive Oxygen Species; Receptors, IgG; Renal Dialysis; Renal Insufficiency, Chronic; Uremia | 2016 |
Inhibition of apoptotic signalling in spermine-treated vascular smooth muscle cells by a novel glutathione precursor.
Topics: Acetylcysteine; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Cystine; Enzyme Activation; Glutathione; Humans; In Situ Nick-End Labeling; JNK Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide Synthase Type II; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Renal Insufficiency, Chronic; Signal Transduction; Spermine | 2010 |
Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Contrast Media; Female; Fluid Therapy; Humans; Iohexol; Kidney; Male; Middle Aged; Osmolar Concentration; Renal Insufficiency, Chronic; Retrospective Studies; Triiodobenzoic Acids | 2005 |
[Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents].
Topics: Acetylcysteine; Administration, Oral; Aged; Cardiac Catheterization; Contrast Media; Coronary Angiography; Critical Pathways; Female; Humans; Kidney Diseases; Male; Middle Aged; Osmolar Concentration; Renal Insufficiency, Chronic; Sodium Bicarbonate | 2007 |